Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Feb;79(2):249-256.
doi: 10.1007/s00228-022-03437-5. Epub 2022 Dec 16.

Premature termination of clinical trials in Spain: reasons, characteristics, and opportunities to improve

Francesca Filippi-Arriaga  1 , Ricardo Javier Boy  2 , Alejandro Díaz Del Gobbo  2 , Alexis Rodríguez Gallego  2   3
Affiliations
Observational Study

Premature termination of clinical trials in Spain: reasons, characteristics, and opportunities to improve

Francesca Filippi-Arriaga et al. Eur J Clin Pharmacol. 2023 Feb.

Abstract

Purpose: The aim of this study is to determine the rate of prematurely terminated clinical trials (CTs) and describe primary reasons and characteristics, and suggest strategies to improve.

Methods: We performed a retrospective, observational, cross-sectional study including all CTs registered in the Spanish Registry of Clinical Studies (REec) from January 1, 2013 to November 31, 2021. A descriptive analysis of reasons for premature termination was made. To assess characteristics associated with a premature termination, the relative risks (RR) with a 95% confidence interval were calculated.

Results: In total, 21% (718) of CT were prematurely terminated. Reasons for premature termination included patient recruitment issues in 25% (179) of cases, efficacy or futility problems in 18% (132), and commercial or strategic decisions from the sponsor in 12% (87). Characteristics significantly associated with an increased risk of premature termination included the following: presence of placebo (RR 2.08); multiple study sites (RR 1.32); pediatric and geriatric populations (RR 1.29 children; RR 1.47 preschoolers; RR 1.92 newborns; RR 1.27 > 64 years of age). In addition, circumstances such as investigations in phase II (RR 1.21), of cancer (RR 1.37), and of digestive pathology (RR 1.65) were also associated with increased risk of premature termination.

Conclusion: Recruitment of the study subjects in a CT must be meticulous and account for age of participants. In addition, CT study sites should be evaluated to ensure they have appropriate resources and the desired patient population. Based on intermediate analyses, CT protocols should describe the criteria to terminate a study due to futility. These approaches are essential to avoid harm to participants, ensure internal validity of studies, and improve the use of resources in CT development.

Keywords: Clinical trial; Database; Futility; Premature termination; Recruitment issues.

PubMed Disclaimer

References

    1. Vargas Castrillón E, Terleira Fernández AI, Gómez Outes A (2013) Luces y sombras en la investigación clínica: 7. Cuestiones éticas y reguladoras de la finalización prematura de los ensayos clínicos. Madrid: Triacastela (7):194–216. https://www.fundaciogrifols.org/es/web/fundacio/-/05-luces-y-sombras-en-... . Accessed 29 Nov 2021
    1. Spain Ministry of Health, Social Services and Equality (2015) Real Decreto 1090/2015, de 4 de diciembre, por el que se regulan los ensayos clínicos con medicamentos, los Comités de Ética de la Investigación con medicamentos y el Registro Español de Estudios Clínicos. https://www.boe.es/eli/es/rd/2015/12/04/1090 . Accessed 29 Nov 2021
    1. European Medicines Agency (2018) ICH E6 (R2) Good clinical practice, European Medicines Agency. Available at: https://www.ema.europa.eu/en/ich-e6-r2-good-clinical-practice . Accessed 29 Nov 2021
    1. Montori VM, Devereaux PJ, Adhikari NKJ, Burns KEA, Eggert CH, Briel M et al (2005) Randomized trials stopped early for benefit: a systematic review. JAMA 294(17):2203–2209. https://doi.org/10.1001/jama.294.17.2203 - DOI
    1. Freidlin B, Korn EL (2009) Stopping clinical trials early for benefit: impact on estimation. Clinical Trials (London, England) 6(2):119–125. https://doi.org/10.1177/1740774509102310.6 - DOI

Publication types

LinkOut - more resources